The dramatic effect of ART on survival among patients with initial CD4 cell counts less than 350 cells/μL is shown in Figure 1A. The hazard of death was higher if patients had lower baseline or latest CD4 cell counts, received ART, or had tuberculosis at baseline (Table 2). This evidence concerns the gene CD4 and tuberculosis.